RESUMO
Objective To explore the risk factors and to develop the management methods of massive perihepatic blood accumulation after liver transplantation. MethocSs Clinical data of 117 patients, who received performed ortho topic liver transplantation in the Department of Biliary Tract Surgery (I) of Eastern Hepatobiliary Surgery Hospital of Second Military Medical University from Mar. 2004 to Apr. 2007, were retrospectively studied to analyze the mdependent risk factors associated with the occurrence of massive perihepatic blood accumulation by univariate analysis andmultivariate analysis, and to summarize the corresponding treatment methods. Results Twelve of 117 cases died ln the perioperative period, and 105 caseswere lncluded in this study. Among 105 cases, 9 (8. 57%) had postoperative massive perihepatic blood accumulation accompanied by aggravated yellowing of the skin and sclera, elevated whole blood leukocyte count and neutrophil proportion in a short period of time, and impaired liver function. Univariate analysis showed the massive perihepatic blood accumulation was associated with a history of upper abdominal surgery (P=0. 001), pre-operative hemoglobin (P= 0. 031), pre-operative leukocyte count (P= 0. 001), pre-operative platelet count (P<0. 001) and post-operative bile leakage (P=0.001); Multivariate analysis showed a history of upper abdominal surgery (P=0. 008, 0R=15. 000) and post-operative bile leakage (P=0. 034, OR=20. 770) were independent risk factors for massive perihepatic blood accumulation. Conclusion The main methods to prevent massive perihepatic blood accumulation include knowing the history of upper abdominal surgery m patients, strictly protecting the blood supply of bile duct, accurate anastomosis and preventing bile leakage. Puncture or removal of hematocele timely is effective for massive perihepatic blood accumulation.
RESUMO
Chemokine is a kind of cytokine that induces cell transport to inflammation sites. It plays an important role in controlling the differentiation, development and directed migration of immunocytes. CCL20 is one of the important members of chemokine family, and it belongs to CC subfamily. Its receptor is CCR6. CCL20 can be expressed in activated monocytes, T lymphocytes, dendritic cells and endothelial cells, and CCR6 can be expressed in liver, lung, and lymphoid tissues. The expression of CCL20 can be induced by tumor necrosis factor α (TNFα), interleukin 1β (IL-1β), IL-17, CD40 ligand and interferon γ (IFN-gamma;). In summary, CCL20 plays an important role in tumor growth, invasion and metastasis (mainly refers to intrahepatic metastasis). Copyright© 2011 by TUMOR.